Cross talk of CCK8 and EGF in mouse neurons

AIM: To explore the mechanism of signaling transduction and cross talk between cholecystokinin octapeptide (CCK₈) and epidermal growth factor (EGF) in mouse neurons and to observe the effect of CCK₈ in coordination with EGF on neuron growth and cell viability. METHODS: For determining which kind of CCK receptor mediated the phosphorylation of EGF receptor, the cultured neurons were randomly divided into control group, CCK₈ stimulation group, CCK_A receptor antagonist group, CCK_B receptor antagonist group, and CCK_A+CCK_B receptor antagonist group. Control and stimulation groups were stimulated with DMEM and CCK₈ (10^-7 mol/L) for 5 min, respectively, while antagonist groups were pre-incubated with different types of receptor antagonists (10^-8 mol/L) for 10 min and followed by stimulating the neurons with CCK₈. For observing the effect of CCK₈ and EGF on the phosphorylation of EGFR in neurons and on neuron growth and cell viability, the cultured neurons were randomly divided into control group, CCK₈ stimulation group, EGF stimulation group and CCK₈+EGF stimulation group, which were stimulated with DMEM, CCK₈ (10^-7 mol/L), EGF (40 μg/L) and CCK₈+EGF for 5 min, respectively. Reactions were terminated by freezing the neurons in liquid nitrogen and the phosphorylated EGFR was detected by Western blotting. Meanwhile, the viability of the neurons was observed by MTT method after stimulated for 24 h, 48 h, 72 h and 96 h. RESULTS: The phosphorylation levels of EGFR were decreased in the neurons treated with either of the two CCK receptor antagonists, and more obvious decrease was observed when the two CCK receptor antagonists were used in combination. Compared with control group, the phosphorylation levels of EGFR in the neurons were significantly increased(P<0.05) after stimulated with CCK₈ or EGF, and the increase was more remarkable in CCK₈+EGF stimulation group. CCK₈ or EGF improved the viability and prolonged the life span of the neuron, and synergism of these two reagents was observed. CONCLUSION: Both CCK_A and CCK_B receptors are involved in the phosphorylation of EGFR in the neurons stimulated by CCK₈, and the type A receptor may play a more important role. There is cross-talk between CCK₈ and EGF signaling pathways in neurons. The signaling cross-talk between CCK₈ and EGF may be the underlying molecular mechanism responsible for the synergistic effect on the neuron growth and viability in vitro.     

Abomasal infusion of casein, starch and soybean oil differentially affect plasma concentrations of gut peptides and feed intake in lactating dairy cows

The effects of specific nutrients on secretion and plasma concentrations of gut peptides (glucagon-like peptide-1((7-36)) amide (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and cholecystokinin-8 (CCK)) differ across species, but are not reported for cattle. Our objective was to determine acute (hours) and chronic (1 week) effects of increased abomasal supply of protein, carbohydrate, or fat to the small intestine on dry matter intake (DMI) and plasma concentrations of GLP-1, GIP, CCK, and insulin. Four mid-lactation Holstein cows were used in a 4 x 4 Latin square design experiment. Treatments were 7-day abomasal infusions of water, soybean oil (500 g/d), corn starch (1100 g/d), or casein (800 g/d). Jugular vein plasma was obtained over 7h at the end of the first and last day of infusions. Oil infusion decreased DMI on day 7, but total metabolizable energy (ME) supply (diet plus infusate) did not differ from water infusion. Casein and starch infusion had no effect on feed DMI; thus, ME supply increased. Decreased DMI on day 7 of oil infusion was accompanied by increased plasma GLP-1 concentration, but decreased plasma CCK concentration. Increased plasma GIP concentration was associated with increased ME supply on day 7 of casein and starch infusion. Casein infusion tended to increase plasma CCK concentration on both days of sampling, and increased plasma GLP-1 and insulin concentration on day 1 of infusion. The present data indicate a sustained elevation of plasma concentration of GLP-1, but not CCK, may contribute to the reduced DMI observed in dairy cows provided supplemental fat.     

The changes in digestive enzymes and hormones of gilthead seabream larvae (Sparus aurata, L 1758) fed on Artemia nauplii enriched with free methionine

Variations in digestive enzymes and hormones during the larval development of gilthead seabream (Sparus aurata) fed on live prey (Artemia nauplii) enriched with free methionine were investigated for 16 days (from day 24 to day 40). Prior to initiation of the experiment, newly hatched larvae were transferred from incubators to fiber glass tanks (300 l) with black walls and fed with same diets until day 24. Each experiment was performed in triplicate. In the experimental group, the content of the free methionine in the Artemia nauplii was increased by adding a 5.3 mM free methionine solution to the culture water during a 16-h enrichment period. The larvae of both the control and enriched-methionine groups were sampled four times, with 4-day intervals between samplings, during a 16-day period. The larvae in the control group had a significantly lower growth than those of the methionine group at the end of the study (P < 0.05). The highest trypsin activity and leucine aminopeptidase N/leucine–alanine peptidase ratios were observed in the control group. A significant difference between bombesin activities in the treatment groups was not found at 5th minute after the initiation of feeding (P > 0.05), but they were significant at 15th minute post-initiation of feeding (P < 0.05). A significant difference between the cholecystokinin levels of the treatment groups was found (P < 0.05).     

Cholecystokinin and neuroprotection

Cholecystokinin (CCK) is one of the first discovered gastrointestinal hormones and one of the most abundant neuropeptides in the brain. CCK, as a neurotransmitter or modulator, is involved in many different biological processes. This review presents an updated overview of the anatomical distribution of CCK in brain, the changes of cerebral CCK gene expression and CCK level during brain injury, the neuroprotective effects of CCK and its underlying mechanisms.     

Effect of cholecystokinin-octapeptide on focal cerebral ischemia/reperfusion injury in rats

AIM:To examine the effect of cholecystokinin-octapeptide (CCK-8) on focal cerebral ischemia/reperfusion injury and its underlying mechanisms.METHODS:By using the suture model of focal cerebral ischemia and reperfusion, the effects of intracerebroventricular (icv) injection of CCK-8 and proglumide, nonselective CCK receptors antagonist, on the infarct size, regional cerebral blood flow (rCBF), and the levels of nitric oxide (NO), malondialdehyde (MDA) were observed in different brain regions of rats subjected to 1 h focal cerebral ischemia followed by 24 h reperfusion.RESULTS:(1) pretreatment with different doses of CCK-8 (0.3 μg,1.0 μg,2.0 μg or 4.0 μg) could attenuate the infarct size, but the statistically significant effects of CCK-8 were obtained only at the doses of 1.0 μg and 2.0 μg(P＜0.05). The neuroprotective effects of CCK-8 were blocked by pretreatment with proglumide. Administration of proglumide alone could worsen the ischemia/reperfusion injury. (2) CCK-8 (1.0 μg) inhibited the increase in NO, MDA levels in the ischemic core, and also inhibited the increase in NO level in the ischemic penumbra. The rCBF in the CCK-8 group was significantly higher than the normal value at 24 h after reperfusion (P＜0.05).CONCLUSIONS:These results suggest that both endogenous and exogenous CCK-8 alleviate focal cerebral ischemia/reperfusion injury. Such an action may be associated with inhibition of free radical-induced injuries and the improvement in rCBF.     

胆囊收缩素的研究进展及其在动物生产中的应用

从两方面阐述了关于CCK的研究进展,一方面为CCK的生物学功能,包括对消化系统的作用、对中枢神经系统的作用、对免疫功能的调节作用及参与CCK调节免疫功能的信号转导机制;另一方面为CCK在动物生产中的应用研究现状,包括CCK与动物的采食量的关系、CCK与单胃动物的关系、CCK抗体与家禽生长性能的关系。     

Effects of CCK-8 and its receptor antagonists on expression of CREB and pCREB in prefrontal cortex and hippocampus of morphine withdrawal rats

AIM：To observe the effects of cholecystokinin octapeptide (CCK-8) and its receptor antagonists on cAMP response element binding protein (CREB) and phosphorylated CREB (pCREB） expression in frontal cortex and hippocampus of morphine withdrawal rats, which aim to explore the post-receptor mechanism through which CCK-8 regulates morphine withdrawal. METHODS：After the morphine dependence and naloxone-precipitated withdrawal animal models were established, the effects of CCK-8, L-364718 (CCK1 receptor antagonist) and LY-288513 (CCK2 receptor antagonist) pretreatment on CREB and pCREB expression in frontal cortex and hippocampus were observed by Western blotting and immunohistochemistry. RESULTS：In rat frontal cortex neuron, CREB was expressed in both cytoplasm and nucleus, but pCREB was only highly expressed in the nucleus. In the pyramidal cell layer of hippocampal CA1 region, CREB showed high expression in the cytoplasm and low expression in the nucleus, while pCREB was only expressed in the nu-cleus. No obvious change of CREB was observed after either chronic morphine treatment or naloxone withdrawal. The pCREB expression was increased after chronic morphine treatment and further increased after naloxone withdrawal. Compared with the withdrawal group, chronic pretreatment with CCK-8, L-364718 and LY-288513 had no effect on CREB expression in the frontal cortex, but obviously decreased the pCREB expression. In the hippocampus, pretreatment with L-364718 and LY-288513 decreased CREB and pCREB expression, but only the pCREB expression was decreased after CCK-8 treatment. CONCLUSION：CCK-8 and CCK receptor antagonists may alleviate morphine withdrawal symptoms by regulating CREB, with specificity in different brain regions.     

Effects of cholecystokinin octapeptide on changes in rabbit thoracic aortic reactivities induced by lipopolysaccharides in vitro

AIM and METHODS: To elucidate the mechanism of anti-endotoxic shock of cholecystokinin octapeptide(CCK-8), the effects of CCK-8 on changes in rabbit thoracic aortic reactivities induced by lipopolysaccharides(LPS) in vitro were studied, and the ultrastructure of the endothelial cells was observed under scanning electron microscope. RESULTS: Incubation of thoracic aortic rings(TARs) with LPS(100 mg/L) resulted in an time-dependent impairment of the endothelium-dependent relaxations to acetylcholine(incubation for 3, 7, 14 h), a reduction of contractive response to phenylphrine(incubation for 14 h) and ultrastructural injury in endothelial cells(incubation for 7 h), all of which were alleviated by concomitant incubation with CCK-8(1 mg/L). In contrast, neither the vascular contractions nor the relaxations were affected by CCK-8 (1 mg/L) alone. CONCLUSION: CCK-8 improved the vascular reactivities in the presence of LPS, which may be one of the anti-endotoxic shock mechanisms of CCK.